{
  "pmid": "26926770",
  "uid": "26926770",
  "title": "US Food and Drug Administration Approval of Flibanserin: Even the Score Does Not Add Up.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Woloshin",
      "fore_name": "Steven",
      "initials": "S",
      "name": "Steven Woloshin",
      "affiliations": [
        "Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire2Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire."
      ]
    },
    {
      "last_name": "Schwartz",
      "fore_name": "Lisa M",
      "initials": "LM",
      "name": "Lisa M Schwartz",
      "affiliations": [
        "Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire2Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire."
      ]
    }
  ],
  "journal": {
    "title": "JAMA internal medicine",
    "iso_abbreviation": "JAMA Intern Med",
    "issn": "2168-6114",
    "issn_type": "Electronic",
    "volume": "176",
    "issue": "4",
    "pub_year": "2016",
    "pub_month": "Apr"
  },
  "start_page": "439",
  "end_page": "442",
  "pages": "439-42",
  "language": "eng",
  "publication_types": [
    "Editorial"
  ],
  "keywords": [
    "Benzimidazoles",
    "Clinical Trials, Phase III as Topic",
    "Drug Approval",
    "Evidence-Based Medicine",
    "Female",
    "Humans",
    "Patient Satisfaction",
    "Sexual Dysfunctions, Psychological",
    "United States",
    "United States Food and Drug Administration"
  ],
  "article_ids": {
    "pubmed": "26926770",
    "doi": "10.1001/jamainternmed.2016.0073",
    "pii": "2497778"
  },
  "doi": "10.1001/jamainternmed.2016.0073",
  "dates": {
    "completed": "2016-08-15",
    "revised": "2016-04-05"
  },
  "chemicals": [
    "Benzimidazoles",
    "flibanserin"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:57:03.521931",
    "pmid": "26926770"
  }
}